Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system

  • Original Article - Epidemiology
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of the research was to analyse the prevalence of ankylosing spondylitis (AS) in Poland and to assess the costs generated by AS patients in the system of public health care. The database of national payer—National Health Fund (NHF)—has been analysed. For the analysis, the information has been extracted from IT system about each treated patient with ICD-10 = M45 code as main or coexisting diagnosis included in the mandatory reports from entities of public healthcare service. In the years 2008–2013, from 28,800 to 32,800 persons diagnosed with AS as main or coexisting diagnosis have been registered in NHF database. In 2013, the prevalence amounted to 7.48 for 10,000 persons of general population—the highest in Kujawy-Pomerania province (10.92 per 10,000 inhabitants), Silesia (10.04) and Świętokrzyskie province (9.81). In male patients, this coefficient amounted to 8.91 per 10,000 inhabitants, whereas in female—to 6.15. In 2013, the prevalence for men was the highest in the age group of 60–64 years and for women in the group of 65–69 years. The healthcare expenses related to AS financed by the NHF increased from 13,200 million PLN (6.3 million USD) in 2008 to 72,600 million PLN (21,900 million USD) in 2013. The increase in healthcare expenses related to AS patients in the public healthcare system is significant and noticeable. High regional diversity is also a vital issue. It is necessary to carry out further research on the incidence rate of AS in Polish population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Notes

  1. Prevalence rate was calculated based on the data of the Central Statistical Office on Poland’s population as of 31.12.2013.

  2. The analysis was carried out based on the data from 2009 of the Supreme Medical Council (number of rheumatologists in provinces), NHF (number of AS patients) and the Central Statistical Office (population in individual provinces).

Abbreviations

NHF:

National Health Fund

AS:

Ankylosing spondylitis

SpA:

Spondyloarthropathies

MHC:

Major histocompatibility complex

AAU:

Acute anterior uveitis

SQL:

Structured query language

References

  1. Stolwijk C, Essers I, van Tubergen A, Boonen A et al (2014) The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis. doi:10.1136/annrheumdis-2014-205253

    Google Scholar 

  2. Stanisławska-Biernat E, Świerkot J, Tłustochowicz W (2012) Spondyloartropatie [Spondyloarthropathies]. Reumatologia 50(2):93–102 Polish

    Google Scholar 

  3. Oliver JE, Silman AJ (2009) What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases. Arthritis Res Ther 11(3):223

    Article  PubMed Central  PubMed  Google Scholar 

  4. Laval SH, Timms A, Edwards S et al (2001) Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 68:918–926

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Roldan CA, Chavez J, Wiest PW et al (1998) Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32:1397–1404

    Article  CAS  PubMed  Google Scholar 

  6. Gouveia EB, Elmann D, de Ávila Saad, Morales M (2012) Ankylosing spondylitis and uveitis: overview. Rev Bras Reumatol. 52(5):742–756

    Article  PubMed  Google Scholar 

  7. Dean LE, Jones GT, Macdonald AG et al (2014) Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53(4):650–657

    Article  Google Scholar 

  8. Rynek Zdrowia (2014) Po Kongresie EULAR: produktywność pacjentów z ZZSK. PWX. [Health Market (2014) After the Congress EULAR: productivity of patients with ankylosing spondylitis. PWX]. http://www.rynekzdrowia.pl/Serwis-Reumatologia/Po-Kongresie-EULAR-produktywnosc-pacjentow-z-ZZSK,143292,1011.html. Accessed 29 July 2014 Polish

  9. Zakład Ubezpieczeń Społecznych (2014) Portal Statystyczny ZUS [Social Insurance Institution (2014) Statistical Portal]. http://www.psz.zus.pl/Default.aspx. Accessed 07 June 2014 Polish

  10. Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 1(3):229

    Article  Google Scholar 

  11. Gran JT, Husby G (2003) Epidemiology of ankylosing spondylitis. [red] Silman AJ, Smolen JS. Weinblatt ME Hochberg MC. Rheumatology 102:1153–1159

    Google Scholar 

  12. Slobodin G, Rosner I, Rimar D et al (2012) Ankylosing spondylitis: field in progress. IMAJ 14:763–767

    PubMed  Google Scholar 

  13. Monjardino T, Lucas R, Lucas H (2011) Frequency of rheumatic diseases in Portugal: a systematic review. Acta Reumatol Port 36:336–363

    PubMed  Google Scholar 

  14. Ochsmann EB, Escobar Pinzón CL, Letzel S, et al (2010) Prevalence of diagnosis and direct treatment costs of back disorders in 644,773 children and youths in Germany. BMC Musculoskelet Disord. http://www.biomedcentral.com/1471-2474/11/193

  15. Anagnostopoulos I, Zinzaras E, Alexiou I et al (2010) The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 11:98. doi:10.1186/1471-2474-11-98

    Article  PubMed Central  PubMed  Google Scholar 

  16. Ustawa z dnia 27.08.2004 r. o świadczeniach opieki zdrowotnej finansowanych ze środków publicznych [Act of 27.08.2004 r. on healthcare services financed from public funds] (Dz. U. Z 2008 r. Nr 164, poz. 1027, z późn. zm.). Polish

  17. Ministerstwo Zdrowia w Polsce [Ministry of Health, Republic of Poland] http://www.mz.gov.pl/wwwmz/index?mr&ms&ml=pl&mi=92&mx=0&ma=10772. Accessed 08 June 2014 Polish

  18. Narodowy Fundusz Zdrowia w Polsce [National Health Fund] http://www.nfz.gov.pl/new/index.php?katnr=3&dzialnr=12. Accessed 08 June 2014 Polish

  19. Międzynarodowa Statystyczna Klasyfikacja Chorób i Problemów Zdrowotnych (2006) Vesalius, Kraków [International Statistical Classification of Diseases and Related Health Problems (2006)] Vesalius, Cracow

  20. Rozporządzenie Parlamentu Europejskiego i Rady w sprawie ochrony osób fizycznych w związku z przetwarzaniem danych osobowych i swobodnym przepływem takich danych (ogólne rozporządzenie o ochronie danych), Komisja Europejska Bruksela [Regulation of the European Parliament and of the Council on the protection of individuals with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation), European Commission, Brussels] (2012). http://www.europarl.europa.eu/meetdocs/2009_2014/documents/com/com_com%282012%290011_/com_com%282012%290011_pl.pdf. Accessed 09 July 2014 Polish

  21. Główny Urząd Statystyczny w Polsce [Central Statistical Office In Poland] http://www.stat.gov.pl. Accessed 09 July 2014 Polish

  22. Śliwczyński A, Czeleko T, Brzozowska M et al (2014) Analysis of public costs of diabetes mellitus care—Poland 2013. Medycyna Metaboliczna 18(4):22–25

    Google Scholar 

  23. Feldtkeller E, Khan MA, van der Heijde D et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative versus positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66

    PubMed  Google Scholar 

  24. Szechiński J, Ebner W, Palotai T, et al (2008) Przekrojowe badanie schematów leczenia, aktywności choroby i jakości życia pacjentów z zesztywniającym zapaleniem stawów kręgosłupa w regionie środkowo-wschodniej Europy, z uwzględnieniem wyników z Polski. [A cross-sectional survey of treatment patterns, disease activity, and quality of life of patients with ankylosing spondylitis in Central and Eastern Europe] Reumatologia. 46 (3): 130–139 Polish

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Public Health, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland

    A. Śliwczyński, M. Brzozowska & T. Czeleko

  2. Department of Drug Administration, National Health Fund, Warsaw, Poland

    A. Śliwczyński, M. Brzozowska, T. Czeleko & T. Jędrzejczyk

  3. Department of Epidemiology and Health Promotion, Institute of Rheumatology, Warsaw, Poland

    F. Raciborski

  4. Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland

    F. Raciborski & A. Kłak

  5. Clinic of Early Arthritis, Institute of Rheumatology, Warsaw, Poland

    B. Kwiatkowska

  6. Department of Health Protection Policy, Medical University of Lodz, Lodz, Poland

    M. Marczak

Authors
  1. A. Śliwczyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Raciborski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Kłak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Brzozowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Czeleko
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Kwiatkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Jędrzejczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Marczak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Kłak.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Śliwczyński, A., Raciborski, F., Kłak, A. et al. Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system. Rheumatol Int 35, 1361–1367 (2015). https://doi.org/10.1007/s00296-015-3247-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3247-8

Keywords

Search

Navigation